{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:09:49Z","timestamp":1790132989978,"version":"4.0.1"},"reference-count":61,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/gme.0b013e31821f92df","type":"journal-article","created":{"date-parts":[[2011,10,19]],"date-time":"2011-10-19T08:22:50Z","timestamp":1319012570000},"page":"109-117","source":"Crossref","is-referenced-by-count":121,"title":["Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women"],"prefix":"10.1097","volume":"19","author":[{"given":"Orkun","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210211","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0015-0282(02)03001-7","article-title":"Hormones, mood, sexuality, and the menopausal transition.","volume":"77","author":"Dennerstein","year":"2002","journal-title":"Fertil Steril"},{"key":"R2-19-20210211","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/archinte.1990.00390130161026","article-title":"Sexual function in the elderly.","volume":"150","author":"Diokno","year":"1990","journal-title":"Arch Intern Med"},{"key":"R3-19-20210211","first-page":"229","article-title":"The high prevalence of sexual concerns among women seeking routine gynecological care.","volume":"49","author":"Nusbaum","year":"2000","journal-title":"J Fam Pract"},{"key":"R4-19-20210211","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/cmt.5.4.357.365","article-title":"Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being.","volume":"5","author":"Floter","year":"2002","journal-title":"Climacteric"},{"key":"R5-19-20210211","first-page":"285","article-title":"Aging and sexuality.","volume":"167","author":"Meston","year":"1997","journal-title":"West J Med"},{"key":"R6-19-20210211","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.maturitas.2009.03.021","article-title":"Menopause and sexuality: prevalence of symptoms and impact on quality of life.","volume":"63","author":"Nappi","year":"2009","journal-title":"Maturitas"},{"key":"R7-19-20210211","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/S0022-5347(01)63188-4","article-title":"Anatomical relationship between urethra and clitoris.","volume":"159","author":"OConnell","year":"1998","journal-title":"J Urol"},{"key":"R8-19-20210211","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/0002-9378(71)90488-1","article-title":"Metabolic clearance and blood production rates of estrogens in postmenopausal women.","volume":"111","author":"Longcope","year":"1971","journal-title":"Am J Obstet Gynecol"},{"key":"R10-19-20210211","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1471-0528.1998.tb10056.x","article-title":"An immunohistochemical study of androgen, oestrogen and progesterone receptors in the vulva and vagina.","volume":"105","author":"Hodgins","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"R11-19-20210211","first-page":"125","article-title":"Hormonal receptors in vulvar tissues.","volume":"6","author":"Onnis","year":"1985","journal-title":"Eur J Gynaecol Oncol"},{"key":"R12-19-20210211","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.physiol.63.1.165","article-title":"Role of estrogen receptor in estrogen action.","volume":"63","author":"Pettersson","year":"2001","journal-title":"Annu Rev Physiol"},{"key":"R13-19-20210211","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.maturitas.2005.06.014","article-title":"Management of post-menopausal vaginal atrophy and atrophic vaginitis.","volume":"52","author":"Castelo-Branco","year":"2005","journal-title":"Maturitas"},{"key":"R14-19-20210211","first-page":"1","article-title":"Estrogens and the urogenital tract. Studies on steroid hormone receptors and a clinical study on a new estradiol-releasing vaginal ring.","volume":"157","author":"Smith","year":"1993","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"key":"R16-19-20210211","first-page":"31","article-title":"Physiology and ecology of the vagina.","volume":"40","author":"Paavonen","year":"1983","journal-title":"Scand J Infect Dis Suppl"},{"key":"R17-19-20210211","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0015-0282(16)42982-1","article-title":"Proteins of human vaginal fluid.","volume":"28","author":"Raffi","year":"1977","journal-title":"Fertil Steril"},{"key":"R18-19-20210211","first-page":"15","article-title":"Effects of estrogen therapy on vaginal physiology during menopause.","volume":"66","author":"Semmens","year":"1985","journal-title":"Obstet Gynecol"},{"key":"R19-19-20210211","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0090-4295(03)00676-9","article-title":"The role of estrogens in female lower urinary tract dysfunction.","volume":"62","author":"Robinson","year":"2003","journal-title":"Urology"},{"key":"R20-19-20210211","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/13697130902814751","article-title":"Urogenital atrophy.","volume":"12","author":"Calleja-Agius","year":"2009","journal-title":"Climacteric"},{"key":"R22-19-20210211","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0378-5122(84)90062-8","article-title":"Sexual expression and its determinants in the post-menopausal woman.","volume":"6","author":"Bachmann","year":"1984","journal-title":"Maturitas"},{"key":"R23-19-20210211","first-page":"461","article-title":"Vulvar transepidermal water loss (TEWL) decay curves. Effect of occlusion, delipidation, and age.","volume":"69","author":"Oriba","year":"1989","journal-title":"Acta Derm Venereol"},{"key":"R25-19-20210211","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0378-5122(03)00082-3","article-title":"Vaginal dryness assessment in postmenopausal women using pH test strip.","volume":"45","author":"Carranza-Lira","year":"2003","journal-title":"Maturitas"},{"key":"R26-19-20210211","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/AOG.0b013e31818aa7c3","article-title":"Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet.","volume":"112","author":"Simon","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R27-19-20210211","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1743-6109.2007.00635.x","article-title":"Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol drospirenone and tibolone, on sexual function in healthy postmenopausal women.","volume":"5","author":"Cayan","year":"2008","journal-title":"J Sex Med"},{"key":"R28-19-20210211","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/13697130802585576","article-title":"Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.","volume":"12","author":"Al-Baghdadi","year":"2009","journal-title":"Climacteric"},{"key":"R34-19-20210211","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/gme.0b013e3181d0f6b9","article-title":"Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society.","volume":"17","year":"2010","journal-title":"Menopause"},{"key":"R35-19-20210211","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1089\/154099902762203704","article-title":"Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy.","volume":"11","author":"Crandall","year":"2002","journal-title":"J Womens Health (Larchmt)"},{"key":"R37-19-20210211","first-page":"823","article-title":"Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms.","volume":"102","author":"Speroff","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R38-19-20210211","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/0378-5122(95)00963-9","article-title":"Clinical trial of the estradiol vaginal ring in the U.S.","volume":"22","author":"Nachtigall","year":"1995","journal-title":"Maturitas"},{"key":"R39-19-20210211","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1471-0528.2000.tb10408.x","article-title":"Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms.","volume":"107","author":"Lose","year":"2000","journal-title":"BJOG"},{"key":"R41-19-20210211","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1743-6109.2005.00131.x","article-title":"Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women.","volume":"2","author":"Goldstein","year":"2005","journal-title":"J Sex Med"},{"key":"R43-19-20210211","first-page":"CD001500","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women.","volume":"4","author":"Suckling","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R45-19-20210211","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00042192-200512020-00020","article-title":"Lasofoxifene (laso), a next generation selective estrogen response modulator (SERM) improves dyspareunia in postmenopausal women with vaginal atrophy (VA) abstract erratum.","volume":"12","author":"Bachmann","year":"2005","journal-title":"Menopause"},{"key":"R46-19-20210211","first-page":"63","article-title":"Lasofoxifene improves symptoms associated with vaginal atrophy abstract.","volume":"11","author":"Bachmann","year":"2004","journal-title":"Menopause"},{"key":"R48-19-20210211","first-page":"675","article-title":"Lasofoxifene, a selective estrogen receptor modulator, improves objective measures of vaginal atrophy.","volume":"11","author":"Portman","year":"2004","journal-title":"Menopause"},{"key":"R50-19-20210211","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/00006254-200007001-00001","article-title":"Selective estrogen receptor modulators in reproductive medicine and biology.","volume":"55","author":"Baker","year":"2000","journal-title":"Obstet Gynecol Surv"},{"key":"R51-19-20210211","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/OGX.0b013e31816400d7","article-title":"Selective estrogen receptor modulators: an update on recent clinical findings.","volume":"63","author":"Shelly","year":"2008","journal-title":"Obstet Gynecol Surv"},{"key":"R52-19-20210211","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0015-0282(03)00358-3","article-title":"Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire.","volume":"79","author":"Lobo","year":"2003","journal-title":"Fertil Steril"},{"key":"R53-19-20210211","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/gme.0b013e3181c1ac01","article-title":"Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study.","volume":"17","author":"Bachmann","year":"2010","journal-title":"Menopause"},{"key":"R54-19-20210211","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2165\/11316000-000000000-00000","article-title":"Tissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptoms.","volume":"27","author":"Archer","year":"2010","journal-title":"Drugs Aging"},{"key":"R55-19-20210211","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/clpt.2010.161","article-title":"Progress and prospects in treating postmenopausal vaginal atrophy.","volume":"89","author":"Winneker","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"R59-19-20210211","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.maturitas.2009.12.017","article-title":"DHEA for postmenopausal women: a review of the evidence.","volume":"66","author":"Panjari","year":"2010","journal-title":"Maturitas"},{"key":"R62-19-20210211","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/152460902753645290","article-title":"Acute dehydroepiandrosterone (DHEA) effects on sexual arousal in postmenopausal women.","volume":"11","author":"Hackbert","year":"2002","journal-title":"J Womens Health Gend Based Med"},{"key":"R63-19-20210211","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1532-5415.2008.01768.x","article-title":"Effects of dehydroepiandrosterone supplementation on cognitive function and quality of life: the DHEA and Well-Ness (DAWN) Trial.","volume":"56","author":"Kritz-Silverstein","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"R64-19-20210211","first-page":"1360","article-title":"Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.","volume":"78","author":"Morales","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"R65-19-20210211","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1210\/jcem-71-3-696","article-title":"The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women.","volume":"71","author":"Mortola","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"R72-19-20210211","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1529-8019.2010.01354.x","article-title":"Atrophic vaginitis.","volume":"23","author":"Stika","year":"2010","journal-title":"Dermatol Ther"},{"key":"R73-19-20210211","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0378-5122(95)00955-8","article-title":"Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women.","volume":"23","author":"Bygdeman","year":"1996","journal-title":"Maturitas"},{"key":"R76-19-20210211","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3816\/CBC.2009.n.037","article-title":"Sexual dysfunction and aromatase inhibitor use in survivors of breast cancer.","volume":"9","author":"Kwan","year":"2009","journal-title":"Clin Breast Cancer"},{"key":"R77-19-20210211","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/0284186X.2010.533190","article-title":"Late effects of breast cancer treatment and potentials for rehabilitation.","volume":"50","author":"Ewertz","year":"2011","journal-title":"Acta Oncol"},{"key":"R78-19-20210211","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/humupd\/dmn064","article-title":"Breast cancer in young women and its impact on reproductive function.","volume":"15","author":"Hickey","year":"2009","journal-title":"Hum Reprod Update"},{"key":"R79-19-20210211","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3109\/07357909909032847","article-title":"Psychosexual implications of breast and gynecologic cancer.","volume":"17","author":"Wilmoth","year":"1999","journal-title":"Cancer Invest"},{"key":"R80-19-20210211","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/jnci\/92.13.1054","article-title":"Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial.","volume":"92","author":"Ganz","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R81-19-20210211","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0378-5122(81)90041-4","article-title":"Endocrinological and clinical investigations in post-menopausal women following administration of vaginal cream containing oestriol.","volume":"3","author":"Haspels","year":"1981","journal-title":"Maturitas"},{"key":"R83-19-20210211","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10549-006-9260-6","article-title":"Quality of life of postmenopausal women in the ATAC (Arimidex, tamoxifen, alone or in combination) trial after completion of 5 years adjuvant treatment for early breast cancer.","volume":"100","author":"Cella","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"R86-19-20210211","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/cmt.6.1.45.52","article-title":"A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer.","volume":"6","author":"Dew","year":"2003","journal-title":"Climacteric"},{"key":"R90-19-20210211","first-page":"197","article-title":"Women and menopause: beliefs, attitudes, and behaviors. The North American Menopause Society 1997 Menopause Survey.","volume":"5","author":"Kaufert","year":"1998","journal-title":"Menopause"},{"issue":"suppl","key":"R91-19-20210211","first-page":"1","article-title":"ACOG Practice Bulletin no. 28: Clinical Management Guidelines for Obstetrician-Gynecologists. Use of botanicals for management of menopausal symptoms.","volume":"97","year":"2001","journal-title":"Obstet Gynecol"},{"key":"R92-19-20210211","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.maturitas.2004.02.008","article-title":"The effects of postmenopausal Vitamin D treatment on vaginal atrophy.","volume":"49","author":"Yildirim","year":"2004","journal-title":"Maturitas"},{"key":"R93-19-20210211","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/gme.0b013e318057787f","article-title":"Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.","volume":"15","author":"Reed","year":"2008","journal-title":"Menopause"},{"key":"R94-19-20210211","first-page":"1","article-title":"New aspects of vulvar cytology.","volume":"26","author":"Nauth","year":"1982","journal-title":"Acta Cytol"},{"key":"R95-19-20210211","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1517\/13543784.2010.532487","article-title":"Bazedoxifene when paired with conjugated estrogens is a new paradigm for treatment of postmenopausal women.","volume":"19","author":"Pinkerton","year":"2010","journal-title":"Expert Opin Investig Drugs"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00042192-201201000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T20:43:40Z","timestamp":1639255420000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-201201000-00019"}},"subtitle":["an up-to-date review"],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e31821f92df","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}